Literature DB >> 6207336

Changes in peripheral and central catecholaminergic and serotoninergic neurons of rats after acute and subacute administration of nicotine.

P Dominiak, F Kees, H Grobecker.   

Abstract

To establish dose-response relationships for nicotine (acute and subacute administration), we measured hemodynamic parameters as well as circulating and tissue catecholamines in sympathetically innervated organs in rats. We also investigated nicotines's influence on adrenoceptor binding sites of the heart and on serotonin metabolism. In conscious and anesthetized rats, we found a dose-dependent increase in circulating catecholamines after acute injection of nicotine. At low doses nicotine released norepinephrine, resulting in a decrease of blood flow and heart rate, whereas high doses of nicotine released epinephrine, resulting in a reversal of the cardiovascular parameters investigated. In the heart norepinephrine concentration increased after nicotine application. In the lung epinephrine rose markedly, whereas serotonin and 5-hydroxyindolacetic acid were diminished. After subacute administration of nicotine the number of binding sites for 3H-Dihydroalprenolol in the heart was significantly reduced, whereas norepinephrine content was increased. Dopamine, serotonin, and 5-hydroxyindolacetic acid were increased in the hypothalamus. Our findings show that nicotine not only affects peripheral and central catecholaminergic neurons, but also central serotoninergic neurons, thus enhancing turnover of these amines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207336

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  2 in total

Review 1.  Glucose for smoking cessation: does it have a role?

Authors:  R West
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Effects of nicotine and its major metabolites on blood pressure in anaesthetized rats.

Authors:  P Dominiak; G Fuchs; S von Toth; H Grobecker
Journal:  Klin Wochenschr       Date:  1985-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.